Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis

The number of elderly hepatocellular carcinoma (HCC) patients is expected to rise. We analyzed the impact of age on clinical presentations, treatment allocation, and long-term survival between elderly (≥75 years) and younger (<75 years) HCC patients. In this study, a total of 812 elderly and 2270...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicine (Baltimore)
Glavni autori: Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2014
Teme:
4500
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4603105/
https://ncbi.nlm.nih.gov/pubmed/25526453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000264
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items